hypertension

October 24, 2014

Immune cells’ role in hypertension

Vanderbilt researchers have discovered that certain immune cells contribute to the development of hypertension, suggesting novel targets for treating the disease.

By Leigh MacMillan

January 29, 2014

Vanderbilt Hypertension Clinic receives national comprehension designation

By Leigh MacMillan

June 6, 2013

Study tracks skin salt’s role in blood pressure control

Clinical pharmacologist Jens Titze, M.D., and his colleagues have identified a new cast of cells and molecules that function in the skin to control sodium balance and blood pressure.

By Leigh MacMillan

January 17, 2013

Laffer named director of Hypertension Service

Cheryl Laffer, M.D., PhD., professor of Medicine, is the new director of the Hypertension Service within the Division of Clinical Pharmacology.

By Kathy Whitney

April 30, 2012

Better blood pressure-reducing drugs?

A newer version of an old class of blood pressure lowering drugs may offer advantages for obese patients with metabolic syndrome.

By Leigh MacMillan

March 9, 2012

Combo combats dizziness

Some patients may need a combo of medications to combat a condition that causes dizziness.

By VUMC News and Communications